Viewing Study NCT01836692


Ignite Creation Date: 2025-12-24 @ 3:34 PM
Ignite Modification Date: 2026-02-23 @ 8:09 PM
Study NCT ID: NCT01836692
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2013-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
Sponsor: Prof Corinne Faivre-Finn
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 11_DOG07_136
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View